Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis

Oncogene

Volumn 34, Issue 35, 2015, Pages 4570-4580

  Bhat, A A ^a   Pope, J L ^a   Smith, J J ^a   Ahmad, R ^a   Chen, X ^a   Washington, M K ^a   Beauchamp, R D ^a   Singh, A B ^a   Dhawan, P ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 7; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; CLAUDIN; CLDN7 PROTEIN, HUMAN; RAB PROTEIN; RAB25 PROTEIN, HUMAN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL ADHESION; CELL INVASION; COLON CARCINOGENESIS; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA METHYLATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE SRC; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ADENOCARCINOMA; ADENOMA; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; COLON TUMOR; EPITHELIUM CELL; HT 29 CELL LINE; METABOLISM; MORTALITY; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ADENOCARCINOMA; ADENOMA; ANIMALS; CARCINOGENESIS; CLAUDINS; COLONIC NEOPLASMS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HT29 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE, NUDE; NEOPLASM TRANSPLANTATION; RAB GTP-BINDING PROTEINS; TRANSCRIPTOME; TUMOR BURDEN;

EID: 84940579204     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.385     Document Type: Article

References (47)

1. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001; 2: 285-293.
2. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-C1228.
3. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999; 20: 1425-1431.
4. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004; 117: 2435-2447.
5. Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Ross JS. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007; 38: 564-5692007.
6. De Oliveira SS, De Oliveira IM, De Souza W, Morgado-Diaz JA. Claudins upregulation in human colorectal cancer. FEBS Lett 2005; 579: 6179-6185.
7. Swisshelm K, Macek R, Kubbies M. Role of claudins in tumorigenesis. Adv Drug Deliv Rev 2005; 57: 919-928.
8. Ding L, Lu Z, Foreman O, Tatum R, Lu Q, Renegar R, Cao J, Chen YH. Inflammation and disruption of the mucosal architecture in claudin-7-deficient mice. Gastroenterology 2012; 142: 305-315.
9. Nam KT, Lee HJ, Smith JJ, Lapierre LA, Kamath VP, Chen X et al. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas. J Clin Invest 2010; 120: 840-849.
10. Cheng JM, Ding M, Aribi A, Shah P, Rao K. Loss of RAB25 expression in breast cancer. Int J Cancer 2006; 118: 2957-2964.
11. Cheng JM, Volk L, Janaki DK, Vyakaranam S, Ran S, Rao KA. Tumor suppressor function of Rab25 in triple-negative breast cancer. Int J Cancer 2010; 126: 2799-2812.
12. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010; 138: 958-968.
13. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 2005; 115: 1765-1776.
14. Casanova JE, Wang X, Kumar R, Bhartur SG, Navarre J, Woodrum JE et al. Rab11a and Rab25 association with the apical recycling system of polarized MDCK cells. Mol Biol Cell 1999; 10: 47-61.
15. Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic 2006; 7: 14-21.
16. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 225-3229.
17. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B et al. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 2001; 61: 2782-2787.
18. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H et al. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000; 97: 6049-6054.
19. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
20. Boireau S, Buchert M, Samuel MS, Pannequin J, Ryan JL, Choquet A et al. DNAmethylation-dependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis 2007; 28: 246-258.
21. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest 2009; 119: 1417-1419.
22. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
23. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-572.
24. Nakayama F, Semba S, Usami Y, Chiba H, Sawada N, Yokozaki H. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 2008; 75: 177-185.
25. Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021-2033.
26. Usami Y, Chiba H, Nakayama F, Ueda J, Matsuda Y, Sawada N et al. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum Pathol 2006; 37: 569-577.
27. Lourenço SV, Coutinho-Camillo CM, Buim ME, de Carvalho AC, Lessa RC, Pereira CM et al. Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma. Histopathology 2010; 57: 689-698.
28. Melchers LJ, Bruine de Bruin L, Schnell U, Slagter-Menkema L, Mastik MF, de Bock GH et al. Lack of claudin-7 is a strong predictor of regional recurrence in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 2013; 49: 998-1005.
29. Yoshizawa K, Nozaki S, Kato A, Hirai M, Yanase M, Yoshimoto T et al. Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Oncol Rep 2013; 29: 445-450.
30. Robertson K. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
31. Laird PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996; 30: 441-464.
32. Toyota M, Ahuja N, Suzuki H, Ohe-Toyota M, Imai K, Imai K et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999; 59: 5438-5442.
33. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 321: 209-213.
34. Issa JP. Cancer prevention: epigenetics steps up to the plate. Cancer Prev Res (Phila Pa) 2008; 1: 219-222.
35. Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 2005; 4: 365-370.
36. Kang Y, Massagué J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-279.
37. Lioni M, Brafford P, Andl C, Rustgi A, El-Deiry W, Herlyn M et al. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am J Pathol 2007; 170: 709-721.
38. Fujita H, Chiba H, Yokozaki H, Sakai N, Sugimoto K, Wada T et al. Differential expression and subcellular localization of claudin-7, -8, -12, -13, and -15 along the mouse intestine. J Histochem Cytochem 2006; 54: 933-944.
39. Lu Z, Ding L, Hong H, Hoggard J, Lu Q, Chen YH. Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp Cell Res 2011; 317: 1935-1946.
40. Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 2013; 4: e915.
41. Park GB, Kim D, Kim YS, Kim S, Lee HK, Yang JW et al. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. Invest Ophthalmol Vis Sci 2014; 55: 1770-1779.
42. Pope JL, Bhat AA, Sharma A, Ahmad R, Krishnan M, Washington MK et al. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut 2014; 63: 622-634.
43. Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, Eschrich S et al. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology 2011; 141: 2140-2153.
44. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD et al. Smad4 regulates claudin-1 expression in a transforming growth factor-b-independent manner in colon cancer cells. Cancer Res 2007; 67: 1571-1579.
45. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the βcatenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2001; 12: 469-476.
46. Caswell PT, Spence HJ, Parsons M, White DP, Clark K, Cheng KW et al. Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 2007; 13: 496-510.
47. Goldenring JR, Nam KT. Rab25 as a tumour suppressor in colon carcinogenesis. Br J Cancer 2011; 104: 33-36.